Penn Vet | Clinical Trial Detail - CLASSIC Plus: Cancer Lifetime Assessment Screening Study in Canines (CLASSiC)
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
Ryan Hospital Philadelphia, PA

CLASSIC Plus: Cancer Lifetime Assessment Screening Study in Canines (CLASSiC)

Aug 29, 2022

The purpose of this clinical trial is to evaluate a validated test (OncoK9) during repeated follow-up visits to demonstrate the benefit and use as a non-invasive tool in cancer detection and monitoring throughout the lifetime of a dog, to reduce cancer related morbidity and mortality.


  • Dogs (of any breed) over 7 years of age or
  • Dogs (predisposed breed) over 4 years of age
    • Breeds highly likely to develop cancer includes: Labrador Retrievers, French bulldogs, German Shepherds, Golden Retrievers, Beagles, Rottweilers, Boxers, Siberian Husky, Bernese Mountain Dogs, Rhodesian Ridgebacks, Flat Coated Retrievers, Sottish Deerhounds, Great Danes, Irish Wolfhounds, or Mastiffs
  • Willing to attend visits for blood collection, as directed (every 3-6 months), for the remainder of your dog’s life


  • All study specific visits will be covered by the study
  • If your dog has suspected cancer via OncoK9 test result, the study will cover some staging tests

CONTACT: If interested, please contact PennVet’s Clinical Investigations Department (VCIC) by phone: 215.573.0302 or email: